检验医学 ›› 2018, Vol. 33 ›› Issue (1): 76-81.DOI: 10.3969/j.issn.1673-8640.2018.01.015

• 综述与讲座 • 上一篇    下一篇

心脏手术相关急性肾损伤的临床实验室检测

武大伟, 宁莉, 魏殿军   

  1. 天津医科大学第二医院检验科,天津 300211
  • 收稿日期:2017-01-09 发布日期:2021-03-18
  • 作者简介:null

    作者简介:武大伟,女,1982年生,硕士,主管技师,主要从事临床生物化学检验工作。

  • 基金资助:
    天津市卫生和计划生育委员会科技基金项目(2015KZ101)

Determinations of cardiac surgery-associated acute kidney injury

WU Dawei, NING Li, WEI Dianjun   

  1. Department of Clinical Laboratory,the Second Hospital of Tianjin Medical University,Tianjin 300211,China
  • Received:2017-01-09 Published:2021-03-18

摘要:

心脏手术相关急性肾损伤(CSA-AKI)是一种常见的心脏手术后并发症,常发展成为慢性肾病,是慢性肾病发病率、死亡率增高的危险因素。患者发生CSA-AKI后死亡率、重症监护病房(ICU)停留时间和住院费用均明显增加。早期诊断CSA-AKI对预防和减少该并发症尤为重要。寻找具有临床应用价值的急性肾损伤早期血清和尿液生物标志物是目前CSA-AKI研究的热点。文章对CSA-AKI的病因、危险因素、分级进行了阐述,并对目前临床实验室新的生物诊断标志物研究进展作一综述。

关键词: 急性肾损伤, 心脏手术, 生物标志物

Abstract:

:Cardiac surgery-associated acute kidney injury (CSA-AKI) is a common complication after cardiac surgery,which can usually develop chronic kidney disease,also resulting with high morbidity and mortality. Mortality,intensive care unit(ICU)residence time and hospitalization costs increase significantly in patients with CSA-AKI. Early diagnosis is important in the prevention and reduction of complications. The research of biomarkers of acute kidney injury in serum and urine is a focus. This review mainly focuses on pathogenesis,risk factors,classification and new early diagnosis biomarkers of CSA-AKI.

Key words: Acute kidney injury, Cardiac surgery, Biomarker

中图分类号: